Blockchain-Pharmaceutical Advancements
Block chains can be used to trace the origin of pharmaceuticals, the transport of drugs, and the procurement of raw materials. Block chain technology also reduces the number of intermediaries involved in the pharmaceutical process, thereby reducing costs and improving safety.
Block chain can enable companies throughout the prescription drug supply chain to verify the authenticity of medicines, expiry dates and other important information. Proponents of Block chain technology say we're on the cusp of a revolution in health care. They envision a future where doctors and institutions share medical records easily, and patients control their personal data rather than letting tech companies harvest our data for free and sell it for profit.
Related Conference of Blockchain-Pharmaceutical Advancements
April 07-08, 2025
4th International Conference and Expo on Pharmaceutics & Novel Drug Delivery Systems
Vancouver, Canada
May 16-17, 2025
8th International Conference on Pharmaceutical Research
&
Innovations in Pharma Industry
Rome, Italy
June 02-03, 2025
31st International Conference on Advanced Clinical Research and Clinical Trials
Amsterdam, Netherlands
June 10-11, 2025
24th International Conference on Medicinal and Pharmaceutical Chemistry
Vancouver, Canada
June 10-11, 2025
7th International Conference and Exhibition on Pharmaceutical Development and Technology
Vancouver, Canada
June 16-17, 2025
18th International Conference and Exhibition on Pharmacovigilance & Drug Safety
Frankfurt, Germany
June 23-24, 2025
25th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry
Paris, France
July 21-22, 2025
11th International Conference on Antimicrobials & Antibiotic Resistance
Vancouver, Canada
August 25-26, 2025
11th International Conference on Pharmaceutical Regulatory Affairs and IPR
Vancouver, Canada
September 08-09, 2025
26th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
Frankfurt, Germany
September 08-09, 2025
13th International Conference and Exhibition on Natural Products and Medicinal Plants Research
Frankfurt, Germany
September 15-16, 2025
42nd International Conference on Drug Discovery and Drug delivery system
Paris, France
September 22-23, 2025
20th International Conference on Pharmaceutical Formulations & Drug Delivery
Toronto, Canada
September 23-24, 2025
10th International Conference on Future Pharma and Innovations
Amsterdam, Netherlands
November 13-14, 2025
28th International Conference and Exhibition on Pharmaceutical Formulations
Aix-en-Provence, France
November 27-28, 2025
4th World Conference on Pharma Industry and Medical Devices
Zurich, Switzerland
Blockchain-Pharmaceutical Advancements Conference Speakers
Recommended Sessions
- Biodrugs, Biomolecules and Therapeutics
- Biomaterials in Drug Delivery
- Biotherapy and Radiopharmaceuticals
- Blockchain-Pharmaceutical Advancements
- Challenges in Pharmaceutical Research
- Digital Therapeutics-Curative Therapies
- Drug Delivery Technologies
- Drug Design and Development
- Drug Discovery and Screening
- Drug Regulatory Affairs
- Drug Targeting and Drug Development
- Molecular Dynamics Simulations
- Novel Developments In Drug Delivery System
- Pharmaceutical Analysis and Quality Assurance
- Pharmaceutical Formulations
- Pharmaceutical Microbiology and Biotechnology
- Pharmaceutical Nanotechnology
- Pharmaceutical Research & Development
- Pharmacogenetics
- Phenotypic Drug Discovery
- Precision Medicine
Related Journals
Are you interested in
- 3D Printing of Drugs - PHARMA CONFERENCE-2025 (France)
- Active Pharmaceutical Ingredients - MedTech-2025 (Switzerland)
- Adaptive Trial Models in Research - Clinical Trials Congress-2025 (France)
- Advanced Analytical Techniques in Drug Development - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Advanced Drug Delivery Systems - PHARMA CONFERENCE-2025 (France)
- Advancements in drug delivery systems - Pharmaceutica-2025 (Canada)
- Advancements in Pharmacovigilance - Clinical Trials Congress-2025 (France)
- Advancements in Psychology Research Methods - Clinical Research 2025 (Netherlands)
- Advances in Cardiovascular Drug Discovery - Cardiovascular-2025 (France)
- Advances in Controlled Release Formulations - Pharmaceutica-2025 (Canada)
- Advances in Drug Discovery - Clinical Trials Congress-2025 (France)
- Advances in Internal Medicine - Pain Management 2025 (Switzerland)
- Advances in Pharmaceutical Packaging - PHARMACEUTICAL SCIENCES 2025 (France)
- Adverse Drug Reactions - PHARMACOVIGILANCE 2025 (Germany)
- Adverse Drug Reactions - Pharmacology 2025 (France)
- Analytical Biotechnology - Biotech-2025 (France)
- Analytical strategies for pharmaceutical products - MedTech-2025 (Switzerland)
- Anesthesia and Critical Care - Pain Management 2025 (Switzerland)
- Antibiotic Prophylaxis - Antibiotics Resistance 2025 (Canada)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics Resistance 2025 (Canada)
- Antibiotic-resistant Bacterial infections - Antibiotics Resistance 2025 (Canada)
- Antibiotics - Antibiotics Resistance 2025 (Canada)
- Antibiotics for Various Diseases and Infections - Antibiotics Resistance 2025 (Canada)
- Antibiotics: In Pregnancy and Lactation - Antibiotics Resistance 2025 (Canada)
- Antimicrobial Peptides - Antibiotics Resistance 2025 (Canada)
- Antimicrobial Therapies - Antibiotics Resistance 2025 (Canada)
- Application of Pharmacology in Medical Science - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Applied Microbiology - Biotech-2025 (France)
- Artificial Intelligence (AI) - Personalizedmedicine-2025 (Switzerland)
- Artificial Intelligence and Machine Learning in Drug Delivery Optimization - Pharmaceutica-2025 (Canada)
- Artificial Intelligence and Machine Learning in Pharmaceutical Chemistry - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Artificial Intelligence in Drug Discovery - PHARMA CONFERENCE-2025 (France)
- BCS and IVIVC Based Biowaivers - Eurobiosimilars 2025 (France)
- Big data analytics and Pharma - Future Pharma 2025 (Netherlands)
- Bio Chemical Pharmacology - Pharmacology 2025 (France)
- Bio Molecular Dynamics - Biotech-2025 (France)
- Bioequivalence and Bioavailability - MedTech-2025 (Switzerland)
- Bioethics and Regulatory Compliance - Clinical Research 2025 (Netherlands)
- Bioinformatics - Pharma Europe 2025 (France)
- Biological Medicine - Eurobiosimilars 2025 (France)
- Biologics and Biosimilars - Pharmaceutica-2025 (Canada)
- Biologics and Biosimilars - PHARMA CONFERENCE-2025 (France)
- Biomarker Discovery in Drug Development - Clinical Trials Congress-2025 (France)
- Biomarkers - Personalizedmedicine-2025 (Switzerland)
- Biomarkers in Cardiovascular Disease and Drug Response - Cardiovascular-2025 (France)
- Biomedical Devices Clinical Research - Clinical Research 2025 (Netherlands)
- Biopharmaceutical Informatics - Eurobiosimilars 2025 (France)
- Biopharmaceutical Sciences - PHARMACOVIGILANCE 2025 (Germany)
- Biopharmaceuticals - Biotech-2025 (France)
- Biopharmaceuticals and Biotechnology - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Biopharmaceutics and Drug Disposition - Pharmaceutica-2025 (Canada)
- Biosimilars - Biotech-2025 (France)
- Biosimilars Approval to Biogenerics in Clinical Practice - Eurobiosimilars 2025 (France)
- Biosimilars Development in Markets - Eurobiosimilars 2025 (France)
- Biosimilars Market and Cost Analysis - Eurobiosimilars 2025 (France)
- Biosimilars Research Pipeline - Eurobiosimilars 2025 (France)
- Biotechnology and Biopharmaceuticals - PHARMA CONFERENCE-2025 (France)
- Cancer Biotechnology - Biotech-2025 (France)
- Cancer Clinical Research Progress - Clinical Trials Congress-2025 (France)
- Cardiac Arrhythmias and Pharmacotherapy - Cardiovascular-2025 (France)
- Cardio protective Agents: Mechanisms and Applications - Cardiovascular-2025 (France)
- Cardio Vascular Pharmacology - Pharmacology 2025 (France)
- Cardiovascular Drug Safety and Toxicology - Cardiovascular-2025 (France)
- Cardiovascular Pharmacology in Special Populations - Cardiovascular-2025 (France)
- Challenges in Biosimilars Pharmacovigilance - Eurobiosimilars 2025 (France)
- Challenges in Drug Formulation and Stability - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Challenges In Pharmaceutical Formulations - Pharmatech 2025 (Canada)
- Chemical and Analytical Strategies for Biosimilars - Eurobiosimilars 2025 (France)
- Classification of pain relief analgesics - Pain Management 2025 (Switzerland)
- Clinical and Hospital Pharmacy - PHARMACEUTICAL SCIENCES 2025 (France)
- Clinical and Hospital Pharmacy - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Clinical and Hospital Pharmacy - PHARMA CONFERENCE-2025 (France)
- Clinical and Hospital Pharmacy - Future Pharma 2025 (Netherlands)
- Clinical and Medical Case Reports - Pharma Europe 2025 (France)
- Clinical and Medical Case Reports - Clinical Research 2025 (Netherlands)
- Clinical Data & Analytics Strategies - Clinical Trials Congress-2025 (France)
- Clinical Data Management and Statistics - Clinical Research 2025 (Netherlands)
- Clinical Pharmacology & Receptor Therapy - Clinical Trials Congress-2025 (France)
- Clinical Pharmacy - Pharma Europe 2025 (France)
- Clinical Pharmacy and Pharmacotherapeutics - Pharmacology 2025 (France)
- Clinical Pharmacy and Pharmacy Practices - MedTech-2025 (Switzerland)
- Clinical Pharmacy and Therapeutics - PHARMACEUTICAL SCIENCES 2025 (France)
- Clinical Research & Clinical Trials - PHARMA CONFERENCE-2025 (France)
- Clinical Research and Drug Development - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Clinical Research Nursing - Clinical Research 2025 (Netherlands)
- Clinical Research Statistics - Pharmacology 2025 (France)
- Clinical Trial Auditing Innovations - Clinical Trials Congress-2025 (France)
- Clinical Trial Efficiency Factors - Clinical Trials Congress-2025 (France)
- Clinical Trials - Clinical Trials Congress-2025 (France)
- Clinical Trials - Personalizedmedicine-2025 (Switzerland)
- Clinical Trials & Safety Monitoring - Clinical Trials Congress-2025 (France)
- Clinical trials and Pharmacovigilance - MedTech-2025 (Switzerland)
- Clinical Trials in Developing Countries - Clinical Research 2025 (Netherlands)
- Clinical Trials on Different Diseases - Clinical Research 2025 (Netherlands)
- Clinical Trials on Various Disorders - PHARMACOVIGILANCE 2025 (Germany)
- Computational Chemistry and Molecular Modeling - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Computer Assisted Drug Design - Biotech-2025 (France)
- Computer-Aided Drug Design - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Consequences of Brexit on Biosimilars - Eurobiosimilars 2025 (France)
- COVID-19 and Drug Repurposing - PHARMA CONFERENCE-2025 (France)
- Current Agency Expectations for Approval for Biosimilars - Eurobiosimilars 2025 (France)
- Current Challenges in Developing Biosimilars - Eurobiosimilars 2025 (France)
- Current Research in Antibiotic Resistance - Antibiotics Resistance 2025 (Canada)
- Cutting-edge Imaging Research - Clinical Trials Congress-2025 (France)
- Data Analytics - Personalizedmedicine-2025 (Switzerland)
- Data Quality Management and Analysis - PHARMACOVIGILANCE 2025 (Germany)
- Decentralized Trial Models - Clinical Trials Congress-2025 (France)
- Design of Clinical Studies and Trials - Clinical Research 2025 (Netherlands)
- Developing Alternatives to Antibiotics - Antibiotics Resistance 2025 (Canada)
- Diagnostics & Medical Devices - Biotech-2025 (France)
- Digital Health - Personalizedmedicine-2025 (Switzerland)
- Digital Health and Telemedicine - PHARMA CONFERENCE-2025 (France)
- Digital Marketing in Pharma Industry - Future Pharma 2025 (Netherlands)
- Digital Pharma - PHARMACEUTICAL SCIENCES 2025 (France)
- Digital Pharma - Pharmatech 2025 (Canada)
- Disease Prevention - Personalizedmedicine-2025 (Switzerland)
- Diversity in Industrial Clinical Trials and Clinical Research - PHARMACOVIGILANCE 2025 (Germany)
- Drug Delivery & Blood-Brain Barrier - Clinical Trials Congress-2025 (France)
- Drug Delivery and Development - Eurobiosimilars 2025 (France)
- Drug Delivery and Gene Therapy - Pharmaceutica-2025 (Canada)
- Drug Delivery for Cardiovascular Diseases - Pharmaceutica-2025 (Canada)
- Drug Delivery in Cancer Therapy - Pharmaceutica-2025 (Canada)
- Drug Delivery in Infectious Diseases - Pharmaceutica-2025 (Canada)
- Drug Delivery Systems - Pharma Europe 2025 (France)
- Drug Delivery Techniques - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Drug Design and Development - Formulations 2025 (France)
- Drug Design, Discovery and Development - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Drug Development - PHARMACEUTICAL SCIENCES 2025 (France)
- Drug Discovery - PHARMACEUTICAL SCIENCES 2025 (France)
- Drug Discovery and Development - Future Pharma 2025 (Netherlands)
- Drug Discovery and Development - Pharmatech 2025 (Canada)
- Drug discovery and NCEs - MedTech-2025 (Switzerland)
- Drug Discovery and Novel Delivery Technologies - Antibiotics Resistance 2025 (Canada)
- Drug Formulation - PHARMACEUTICAL SCIENCES 2025 (France)
- Drug Formulation Procedures - Formulations 2025 (France)
- Drug Product Manufacturing - Pharmatech 2025 (Canada)
- Drug Product Manufacturing - Formulations 2025 (France)
- Drug Regulations - Pharma Europe 2025 (France)
- Drug Repurposing in Cardiovascular Medicine - Cardiovascular-2025 (France)
- Drug Safety Testing - Pharmacology 2025 (France)
- Drug Screening and Discovery - Pharmacology 2025 (France)
- Drug Targeting and Design - Pharmaceutica-2025 (Canada)
- Drug Targeting and Design - Pharmatech 2025 (Canada)
- Ecopharmacovigilance - Pharmacology 2025 (France)
- Electronic Health Records (EHRs) - Personalizedmedicine-2025 (Switzerland)
- Emerging Antithrombotic Therapies - Cardiovascular-2025 (France)
- Emerging Biosimilars in Therapeutics - Eurobiosimilars 2025 (France)
- Endothelial Nitric Oxide and Cardiovascular Health - Cardiovascular-2025 (France)
- Entrepreneurs Investment Meet - PHARMACEUTICAL SCIENCES 2025 (France)
- Epidemiology and Public Health - Clinical Research 2025 (Netherlands)
- Epigenetic Therapies in Cancer - PHARMA CONFERENCE-2025 (France)
- Forensic Toxicology - Pharmacology 2025 (France)
- Formulation Strategies for Follow-on Biologics - Eurobiosimilars 2025 (France)
- Formulations and NNDS - MedTech-2025 (Switzerland)
- Future of Clinical Trials - Clinical Research 2025 (Netherlands)
- Gaseous Dosage Forms - Formulations 2025 (France)
- General Considerations in Dosage Forms - Formulations 2025 (France)
- Generics versus Big Pharma - PHARMACEUTICAL SCIENCES 2025 (France)
- Genetic Testing - Personalizedmedicine-2025 (Switzerland)
- Genomics - Personalizedmedicine-2025 (Switzerland)
- Globalization of Biosimilars - Eurobiosimilars 2025 (France)
- Globalized Pharma Sector - PHARMACEUTICAL SCIENCES 2025 (France)
- Good Pharmacovigilance Practice - PHARMACOVIGILANCE 2025 (Germany)
- Green and Community Pharmacy - Future Pharma 2025 (Netherlands)
- Green Chemistry in Pharmaceutical Development - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Health Equity - Personalizedmedicine-2025 (Switzerland)
- Hereditary Angioedema Research - Clinical Trials Congress-2025 (France)
- Hydrogel-Based Delivery for Diabetes - PHARMA CONFERENCE-2025 (France)
- Immunology & Vaccines - Antibiotics Resistance 2025 (Canada)
- Immunopharmacology - Pharmacology 2025 (France)
- Industrial and Physical Pharmacy - PHARMACEUTICAL SCIENCES 2025 (France)
- Industrial Bioproceses for Drug Production and Development - Biotech-2025 (France)
- Industrial Pharmacy - Pharma Europe 2025 (France)
- Industrial Pharmacy and Physical pharmacy - Future Pharma 2025 (Netherlands)
- Infectious Diseases - Antibiotics Resistance 2025 (Canada)
- Innovations in Clinical Trials - Clinical Research 2025 (Netherlands)
- Innovations in Heart Failure Pharmacotherapy - Cardiovascular-2025 (France)
- Innovations In Pharmaceutical Technology - Pharmatech 2025 (Canada)
- Innovations in Pre-Clinical Research - Clinical Research 2025 (Netherlands)
- Innovative Clinical Approach in Biosimilars - Eurobiosimilars 2025 (France)
- Innovative Drug Design and Discovery - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Intellectual Property Rights - Eurobiosimilars 2025 (France)
- Interventional Pain Management - Pain Management 2025 (Switzerland)
- Latest technologies in Biomedical Research - Clinical Research 2025 (Netherlands)
- Legal Issues and BPCI Act - Eurobiosimilars 2025 (France)
- Lifestyle Medicine - Personalizedmedicine-2025 (Switzerland)
- Lipids and Cholesterol Management in Cardiovascular Disease - Cardiovascular-2025 (France)
- Liquid Dosage Forms - Formulations 2025 (France)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics Resistance 2025 (Canada)
- Medicinal Chemistry - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Medicinal Chemistry and Targeted Therapies - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Medicinal Chemistry: Physical Properties and Drug Design - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Medico Marketing - PHARMACEUTICAL SCIENCES 2025 (France)
- Micro Organisms in Recent Drug Discovery - Antibiotics Resistance 2025 (Canada)
- Microbial & Environmental Biotechnology - Biotech-2025 (France)
- Microbiology Clinical Research - Clinical Research 2025 (Netherlands)
- Microorganisms Producing Antibiotics - Antibiotics Resistance 2025 (Canada)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics Resistance 2025 (Canada)
- Molecualr Biotechnology - Biotech-2025 (France)
- Molecular and Clinical Pharmacology - Pharmacology 2025 (France)
- Molecular Mechanisms of Cardiovascular Pharmacology - Cardiovascular-2025 (France)
- Monoclonal Antibody Biosimilars - Eurobiosimilars 2025 (France)
- Nano medicine and Nanotechnology in Drug Delivery - Pharmaceutica-2025 (Canada)
- Nanomedicine and Nano Technology - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Nanomedicine in Cardiovascular Pharmacology - Cardiovascular-2025 (France)
- Nanotechnology in Drug Delivery - Pharma Europe 2025 (France)
- Nanotechnology in Drug Delivery Systems - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Nanotechnology in Drug Discovery - Clinical Trials Congress-2025 (France)
- Natural Products and Traditional Medicine - PHARMA CONFERENCE-2025 (France)
- Natural Products Chemistry - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Neuro Pharmacology - Pharmacology 2025 (France)
- New antibiotics and non-antibiotic approaches - Antibiotics Resistance 2025 (Canada)
- Next-Gen Drug Design Techniques - Clinical Trials Congress-2025 (France)
- Non-Pharmacological Approaches for Pain - Pain Management 2025 (Switzerland)
- Novel Drug Delivery Systems - Future Pharma 2025 (Netherlands)
- Novel Drug Delivery Systems - Formulations 2025 (France)
- Novel Drug Delivery Systems, Biomarkers & Drug Targets - MedTech-2025 (Switzerland)
- Novel Drug Delivery Technologies - Pharmaceutica-2025 (Canada)
- Novel Target Drugs to the Treatment of Cancer - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Novel Targets in Hypertension Therapy - Cardiovascular-2025 (France)
- NSAIDs and Analgesics - Pain Management 2025 (Switzerland)
- Ocular Pharmacology - Pharmacology 2025 (France)
- Oncology Clinical Research - Clinical Research 2025 (Netherlands)
- Organic Chemistry in Pharmaceuticals - Clinical Trials Congress-2025 (France)
- Pain Management and Rehabilitation - Pain Management 2025 (Switzerland)
- Pain Medicine - Pain Management 2025 (Switzerland)
- Patient Recruiting & Retention - Clinical Research 2025 (Netherlands)
- Patient-Cantered Care - Personalizedmedicine-2025 (Switzerland)
- Peptide and Protein Drug Delivery - Pharmaceutica-2025 (Canada)
- Personalized Healthcare - Personalizedmedicine-2025 (Switzerland)
- Personalized Medicine in Cardiovascular Care - Cardiovascular-2025 (France)
- Pharma and Biotech Financial Outlook - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharma and Biotech Financial Outlook - Future Pharma 2025 (Netherlands)
- Pharma Companies - Pharma Europe 2025 (France)
- Pharma Market Research - MedTech-2025 (Switzerland)
- Pharmaceutical Analysis - Future Pharma 2025 (Netherlands)
- Pharmaceutical Analysis - Pharmatech 2025 (Canada)
- Pharmaceutical Analysis - Formulations 2025 (France)
- Pharmaceutical Analysis: Analytical Methods - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmaceutical and healthcare Industry - Future Pharma 2025 (Netherlands)
- Pharmaceutical Biotechnology - Pharma Europe 2025 (France)
- Pharmaceutical Chemistry - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmaceutical Chemistry - Pharma Europe 2025 (France)
- Pharmaceutical Chemistry - Future Pharma 2025 (Netherlands)
- Pharmaceutical Chemistry - Pharmatech 2025 (Canada)
- Pharmaceutical Engineering - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Engineering - Pharma Europe 2025 (France)
- Pharmaceutical Excipients - Formulations 2025 (France)
- Pharmaceutical Formulation - Formulations 2025 (France)
- Pharmaceutical Formulation Advances - Clinical Trials Congress-2025 (France)
- Pharmaceutical Formulations - Pharma Europe 2025 (France)
- Pharmaceutical Industry - Pharmatech 2025 (Canada)
- Pharmaceutical Industry and Market Trends - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Pharmaceutical Manufacturing and Pharmacoeconomics - MedTech-2025 (Switzerland)
- Pharmaceutical Manufacturing, Scale Up and Tech transfer - MedTech-2025 (Switzerland)
- Pharmaceutical Marketing - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmaceutical Microbiology - Pharma Europe 2025 (France)
- Pharmaceutical Microbiology and Biotechnology - PHARMA CONFERENCE-2025 (France)
- Pharmaceutical Nanotechnology - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Nanotechnology - Pharma Europe 2025 (France)
- Pharmaceutical Packaging and Logistics - MedTech-2025 (Switzerland)
- Pharmaceutical Process Validation - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Research and Development - Pharmatech 2025 (Canada)
- Pharmaceutical Science - Pharmatech 2025 (Canada)
- Pharmaceutical sciences - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Sciences - Pharma Europe 2025 (France)
- Pharmaceutical Sciences - MedTech-2025 (Switzerland)
- Pharmaceutical Supply Chain Optimization - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Technology - Clinical Trials Congress-2025 (France)
- Pharmaceuticals and Cosmetics - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmaceutics - Pharma Europe 2025 (France)
- Pharmaceutics & Pharmacotherapeutics - Future Pharma 2025 (Netherlands)
- Pharmaceutics and Pharmacotherapeutics - Pharmatech 2025 (Canada)
- Pharmacists Role in Patient Safety - Pharmatech 2025 (Canada)
- Pharmacoeconomics - MedTech-2025 (Switzerland)
- Pharmacogenetics - Personalizedmedicine-2025 (Switzerland)
- Pharmacogenetics & Pharmacogenomics - PHARMA CONFERENCE-2025 (France)
- Pharmacogenomics - Personalizedmedicine-2025 (Switzerland)
- Pharmacogenomics and Pharmacoepidemiology - MedTech-2025 (Switzerland)
- Pharmacogenomics in Cardiovascular Medicine - Cardiovascular-2025 (France)
- Pharmacognosy - Pharma Europe 2025 (France)
- Pharmacokinetics and Pharmacodynamics - Pharmaceutica-2025 (Canada)
- Pharmacokinetics and Pharmacodynamics - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmacokinetics and Pharmacodynamics - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Pharmacokinetics and Pharmacodynamics in Cardiology - Cardiovascular-2025 (France)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics Resistance 2025 (Canada)
- Pharmacological Approaches for Pain - Pain Management 2025 (Switzerland)
- Pharmacological Approaches to Myocardial Ischemia - Cardiovascular-2025 (France)
- Pharmacological Management of Cardiovascular Risk Factors - Cardiovascular-2025 (France)
- Pharmacological Sciences - Pharma Europe 2025 (France)
- Pharmacology - Pharmatech 2025 (Canada)
- Pharmacology - Pharmacology 2025 (France)
- Pharmacology & Toxicology - Antibiotics Resistance 2025 (Canada)
- Pharmacology and Toxicology - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmacology and Toxicology - MedTech-2025 (Switzerland)
- Pharmacovigilance and Drug Safety - PHARMA CONFERENCE-2025 (France)
- Pharmacovigilance and Drug Safety - Clinical Research 2025 (Netherlands)
- Pharmacovigilance and Risk Management - PHARMACOVIGILANCE 2025 (Germany)
- Pharmacovigilance Significance & Scope - PHARMACOVIGILANCE 2025 (Germany)
- Pharmacovigilance Significance and Scope - Pharmacology 2025 (France)
- Pharmacy Development Services - Pharma Europe 2025 (France)
- Pharmacy Education and Practice - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmacy Practices and its Challenges - PHARMACOVIGILANCE 2025 (Germany)
- Population Health - Personalizedmedicine-2025 (Switzerland)
- Post-Marketing Surveillance Insights - Clinical Trials Congress-2025 (France)
- Post-Trial Closed Communities - Clinical Trials Congress-2025 (France)
- Pre-clinical and Clinical Trails - Pharmacology 2025 (France)
- Pre-Clinical and Clinical Trials - PHARMACOVIGILANCE 2025 (Germany)
- Precision Medicine - Personalizedmedicine-2025 (Switzerland)
- Purpose and Principles of GMP - PHARMACEUTICAL SCIENCES 2025 (France)
- QC & QA: Quality control and Quality assurance - MedTech-2025 (Switzerland)
- Quality by design (QbD) approach - MedTech-2025 (Switzerland)
- Quality Control and Regulatory Considerations in Drug Delivery Systems - Pharmaceutica-2025 (Canada)
- R&D Advancement: Road to New Medicines - PHARMACEUTICAL SCIENCES 2025 (France)
- Rational Design of Non-Oral Drugs - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Rational Drug Design and Molecular Modeling - PHARMA CONFERENCE-2025 (France)
- Real-World Evidence in Clinical Trials - Pharma Europe 2025 (France)
- Real-World Evidence in Clinical Trials - Clinical Research 2025 (Netherlands)
- Recent Advancements in Medicinal Pharma - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Recent Advances in Pharmacology and Toxicology - Pharmacology 2025 (France)
- Recent Advances in Pharmacology and Toxicology - Pharmacology 2025 (France)
- Regenerative Medicine - Pain Management 2025 (Switzerland)
- Regulatory Affairs and Drug Safety - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Regulatory Affairs and Intellectual Property Rights - Future Pharma 2025 (Netherlands)
- Regulatory Affairs and Quality Assurance in Pharmaceutics - Pharmaceutica-2025 (Canada)
- Regulatory Authority Compliance - MedTech-2025 (Switzerland)
- Regulatory Requirements for Pharmaceuticals - PHARMACEUTICAL SCIENCES 2025 (France)
- Regulatory Updates on Biosimilars - Eurobiosimilars 2025 (France)
- Role of Gut Microbiome in Cardiovascular Health - Cardiovascular-2025 (France)
- Role of Inflammation in Cardiovascular Diseases - Cardiovascular-2025 (France)
- Safety Pharmacology - Pharmacology 2025 (France)
- Semi-Solid Dosage Forms - Formulations 2025 (France)
- Site Management Innovation - Clinical Research 2025 (Netherlands)
- Smart Drug Delivery Systems - Pharmatech 2025 (Canada)
- Smart Drug Delivery Systems - Formulations 2025 (France)
- Smart Polymers for Drug Delivery - Pharmaceutica-2025 (Canada)
- Solid Dosage Forms - Formulations 2025 (France)
- Stem Cell and Genetic Clinical Research - Clinical Research 2025 (Netherlands)
- Sustainability and Global Health Biotechnology - Biotech-2025 (France)
- Synthetic and Bioorganic Chemistry - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Targeted Drug Delivery and Controlled Release Systems - PHARMA CONFERENCE-2025 (France)
- Targeted Therapies - Personalizedmedicine-2025 (Switzerland)
- Targeted Therapies in Cardiovascular Regeneration - Cardiovascular-2025 (France)
- Targeting the Renin-Angiotensin-Aldosterone System (RAAS) - Cardiovascular-2025 (France)
- Technology in Pharma Sciences - MedTech-2025 (Switzerland)
- Telemedicine - Personalizedmedicine-2025 (Switzerland)
- The Future of Pharma R&D - Future Pharma 2025 (Netherlands)
- The Next Generation Approach of Antibiotics - Antibiotics Resistance 2025 (Canada)
- Toxicology - Pharmacology 2025 (France)
- Translational Research - Personalizedmedicine-2025 (Switzerland)
- Types of Formulations - Formulations 2025 (France)
- USFDA Approved Biosimilars - Eurobiosimilars 2025 (France)
- Vaccine Delivery Systems - Pharmaceutica-2025 (Canada)
- Vaccine Design and Drug Design - PHARMA CONFERENCE-2025 (France)
- Vascular Pharmacology: Focus on Endothelial Dysfunction - Cardiovascular-2025 (France)
- Wearable Drug Delivery Systems - PHARMA CONFERENCE-2025 (France)